Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency

Ann Allergy Asthma Immunol. 2021 Sep;127(3):383-384. doi: 10.1016/j.anai.2021.05.015. Epub 2021 May 19.

Authors

Jacqueline Squire¹, Avni Joshi²

Affiliations

¹ Division of Pulmonary, Allergy, and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Florida.
² Division of Allergic Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: joshi.avni@mayo.edu.

No abstract available

MeSH terms

Adult
Aged
Antibodies, Viral / biosynthesis*
COVID-19 / immunology
COVID-19 / prevention & control*
COVID-19 Vaccines / administration & dosage*
Female
Humans
Immunity, Cellular / drug effects
Immunity, Humoral / drug effects*
Immunoglobulins, Intravenous / therapeutic use
Immunologic Deficiency Syndromes / drug therapy*
Immunologic Deficiency Syndromes / immunology
Immunologic Deficiency Syndromes / pathology
Male
Middle Aged
Retrospective Studies
SARS-CoV-2 / immunology
Seroconversion*
Vaccination / methods

Substances

Antibodies, Viral
COVID-19 Vaccines
Immunoglobulins, Intravenous